These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30977712)

  • 21. Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study.
    Irimia P; García-Azorín D; Núñez M; Díaz-Cerezo S; de Polavieja PG; Panni T; Sicras-Navarro A; Sicras-Mainar A; Ciudad A
    J Headache Pain; 2022 Jul; 23(1):78. PubMed ID: 35794535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of use and health expenses associated with triptans among adults with migraines.
    Wu J; Noxon V; Lu ZK
    Clin J Pain; 2015 Aug; 31(8):673-9. PubMed ID: 25185875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
    J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting initiation of preventive migraine medications: exploratory study in a large U.S. medical claims database.
    Ford JH; Schroeder K; Buse DC; Joshi S; Gelwicks S; Foster SA; Aurora SK
    Curr Med Res Opin; 2020 Jan; 36(1):51-61. PubMed ID: 31422701
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
    Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
    Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic burden and risk factors of migraine disease progression in the US: a retrospective analysis of a commercial payer database.
    Foster SA; Chen CC; Ding Y; Mason O; McGuiness CB; Morrow P; Ye W; Wade RL; Smith TR; Joshi S
    J Med Econ; 2020 Nov; 23(11):1356-1364. PubMed ID: 32845189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Lipton RB; Munjal S; Alam A; Buse DC; Fanning KM; Reed ML; Schwedt TJ; Dodick DW
    Headache; 2018 Oct; 58(9):1408-1426. PubMed ID: 30341895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine.
    Shewale AR; Brandenburg JA; Burslem K; Lipton RB; Doshi JA
    Cephalalgia; 2024 Feb; 44(2):3331024241235139. PubMed ID: 38410849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Marginal health care expenditures and health-related quality of life burden in patients with migraine.
    Masurkar PP; Goswami S
    J Manag Care Spec Pharm; 2024 Oct; 30(10):1149-1159. PubMed ID: 39321120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Headache-Free Days on Disability, Productivity, Quality of Life, and Costs Among Individuals with Migraine.
    Lipton RB; Lee L; Saikali NP; Bell J; Cohen JM
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1344-1352. PubMed ID: 32678720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
    Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin type A and acute drug costs in migraine with triptan overuse.
    Christie SN; Giammarco R; Gawel M; Mackie G; Gladstone J; Becker WJ
    Can J Neurol Sci; 2010 Sep; 37(5):588-94. PubMed ID: 21059503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
    Bigal ME; Serrano D; Reed M; Lipton RB
    Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of medications for migraine in Aotearoa New Zealand.
    Imlach F; Garrett S
    N Z Med J; 2024 Jul; 137(1599):65-87. PubMed ID: 39024586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimigraine medication use and associated health care costs in employed patients.
    Wu J; Hughes MD; Hudson MF; Wagner PJ
    J Headache Pain; 2012 Mar; 13(2):121-7. PubMed ID: 22127427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
    Messali A; Sanderson JC; Blumenfeld AM; Goadsby PJ; Buse DC; Varon SF; Stokes M; Lipton RB
    Headache; 2016 Feb; 56(2):306-22. PubMed ID: 26833083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct cost burden among insured US employees with migraine.
    Hawkins K; Wang S; Rupnow M
    Headache; 2008 Apr; 48(4):553-63. PubMed ID: 18070057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns and predictors of prescription medication use in the management of headache: findings from the 2000 Medical Expenditure Panel Survey.
    Devine JW; Farley JF; Hadsall RS
    Headache; 2005 Oct; 45(9):1171-80. PubMed ID: 16178947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.